Elanco Animal Health’s (NASDAQ:ELAN) lock-up period will expire on Tuesday, March 19th. Elanco Animal Health had issued 62,900,000 shares in its IPO on September 20th. The total size of the offering was $1,509,600,000 based on an initial share price of $24.00. After the expiration of Elanco Animal Health’s lock-up period, major shareholders and company insiders will be able to sell their shares of the company.
ELAN has been the subject of a number of recent analyst reports. Argus initiated coverage on Elanco Animal Health in a research note on Tuesday, January 15th. They issued a “buy” rating and a $37.00 price target for the company. Zacks Investment Research raised Elanco Animal Health from a “hold” rating to a “buy” rating and set a $36.00 price target for the company in a research note on Monday, December 17th. Morgan Stanley initiated coverage on Elanco Animal Health in a research note on Wednesday, March 13th. They issued an “equal weight” rating and a $34.00 price target for the company. Credit Suisse Group reaffirmed a “hold” rating and issued a $36.00 price target on shares of Elanco Animal Health in a research note on Monday, December 17th. Finally, BMO Capital Markets lowered their price target on Elanco Animal Health from $37.00 to $32.00 and set a “market perform” rating for the company in a research note on Wednesday, December 19th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating to the company. The company presently has a consensus rating of “Hold” and an average target price of $33.48.
NASDAQ ELAN opened at $30.64 on Monday. Elanco Animal Health has a 52-week low of $28.00 and a 52-week high of $37.61.
Elanco Animal Health (NASDAQ:ELAN) last posted its earnings results on Wednesday, February 6th. The company reported $0.29 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.26 by $0.03. The business had revenue of $799.30 million for the quarter, compared to the consensus estimate of $804.07 million. During the same period in the previous year, the company posted $0.12 earnings per share. Elanco Animal Health’s revenue for the quarter was up 6.0% compared to the same quarter last year.
In other Elanco Animal Health news, Director R David Hoover bought 20,000 shares of the stock in a transaction that occurred on Wednesday, March 13th. The stock was acquired at an average cost of $31.43 per share, with a total value of $628,600.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link.
A number of hedge funds and other institutional investors have recently bought and sold shares of ELAN. Morgan Stanley bought a new position in shares of Elanco Animal Health during the 3rd quarter worth approximately $314,448,000. Amundi Pioneer Asset Management Inc. grew its stake in shares of Elanco Animal Health by 115,239.6% during the 4th quarter. Amundi Pioneer Asset Management Inc. now owns 5,766,978 shares of the company’s stock worth $181,833,000 after acquiring an additional 5,761,978 shares in the last quarter. Vanguard Group Inc bought a new position in shares of Elanco Animal Health during the 3rd quarter worth approximately $176,182,000. Vanguard Group Inc. bought a new position in shares of Elanco Animal Health during the 3rd quarter worth approximately $176,182,000. Finally, FMR LLC grew its stake in shares of Elanco Animal Health by 34.5% during the 4th quarter. FMR LLC now owns 4,415,172 shares of the company’s stock worth $139,210,000 after acquiring an additional 1,131,504 shares in the last quarter.
COPYRIGHT VIOLATION WARNING: “Elanco Animal Health’s Lock-Up Period To Expire Tomorrow (NASDAQ:ELAN)” was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was copied illegally and republished in violation of international trademark & copyright law. The original version of this article can be accessed at https://www.dispatchtribunal.com/2019/03/18/elanco-animal-healths-lock-up-period-to-expire-tomorrow-nasdaqelan.html.
Elanco Animal Health Company Profile
There is no company description available for Elanco Animal Health Inc
Featured Story: How Does the Quiet Period Work?
Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.